Baxa Corporation Expands Headquarters Facilities

Denver, CO, February 27, 2005 --(PR.com)-- Baxa Corporation announces the addition of a new building to its corporate headquarters. The expansion provides a 15,000 square-foot facility accommodating the sales, marketing and technical support operations for the medical device manufacturer. Two years after the company built a state-of-the-art production facility in Englewood, Colorado, unprecedented business growth constrained the office and administration space.

“We never expected to outgrow the Grasslands facility so quickly,” says Greg Baldwin, Baxa Chairman and CEO. “Our long-term plan is to create a campus with several buildings housing the manufacturing, customer service and support and new product development activities.” Double-digit sales growth moved up the timeline for the addition of office space for the company, which was able to accomplish the planning, building and move in less than six months. “Baxa has a reputation for outstanding customer service. We were fortunate to be able to accomplish the entire project without impacting our customers. Technical support and customer service associates made a smooth transition to the new facility, while day-to-day operations were uninterrupted,” Baldwin adds.

With this office expansion, Baxa Corporation has the space for planned expansion in its hardware and software development teams. As a privately held company, Baxa invests profits in R&D and new product planning activities, providing significant opportunity for future
growth.

Note: The Baxa corporation mailing address (14445 Grasslands Drive, Englewood, Colorado 80112-7062), phone numbers and e-mail addresses remain unchanged with this expansion.

Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Baxa Corporation is privately held, with subsidiaries and sales offices in Canada, the United Kingdom; Denmark, and Germany; and distribution partners worldwide. Further information is available at http://www.baxa.com.

For More Information, Contact:
Marian Robinson, Vice President, Marketing, Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Maggie Chamberlin Holben, APR, Absolutely Public Relations: 303.984.9801 or 303.669.3558

###